BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10654800)

  • 1. The role of cAMP-MAPK signalling in the regulation of human hepatocellular carcinoma growth in vitro.
    Schmidt CM; McKillop IH; Cahill PA; Sitzmann JV
    Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1393-9. PubMed ID: 10654800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory guanine nucleotide regulatory protein activation of mitogen-activated protein kinase in experimental hepatocellular carcinoma in vitro.
    McKillop IH; Schmidt CM; Cahill PA; Sitzmann JV
    Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):761-8. PubMed ID: 10445797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
    Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
    Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of inhibitory guanine nucleotide regulatory proteins (Gi-proteins) in experimental hepatocellular carcinoma.
    McKillop IH; Wu Y; Cahill PA; Sitzmann JV
    J Cell Physiol; 1998 Jun; 175(3):295-304. PubMed ID: 9572474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Gi-protein-mediated mitogenesis following chronic ethanol exposure in a rat model of experimental hepatocellular carcinoma.
    McKillop IH; Vyas N; Schmidt CM; Cahill PA; Sitzmann JV
    Hepatology; 1999 Feb; 29(2):412-20. PubMed ID: 9918917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Gq/G11 guanine nucleotide regulatory protein expression in a rat model of hepatocellular carcinoma: role in mitogenesis.
    McKillop IH; Schmidt CM; Cahill PA; Sitzmann JV
    Hepatology; 1999 Feb; 29(2):371-8. PubMed ID: 9918912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cyclic-AMP responsive element binding (CREB) proteins in cell proliferation in a rat model of hepatocellular carcinoma.
    Kovach SJ; Price JA; Shaw CM; Theodorakis NG; McKillop IH
    J Cell Physiol; 2006 Feb; 206(2):411-9. PubMed ID: 16110470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of fatty acid-CoA ligase 4 in hepatocellular carcinoma growth: roles of cyclic AMP and p38 mitogen-activated protein kinase.
    Liang YC; Wu CH; Chu JS; Wang CK; Hung LF; Wang YJ; Ho YS; Chang JG; Lin SY
    World J Gastroenterol; 2005 May; 11(17):2557-63. PubMed ID: 15849811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of cAMP-stimulated mitogenesis from activation of the mitogen-activated protein kinase cascade in Swiss 3T3 cells.
    Withers DJ; Bloom SR; Rozengurt E
    J Biol Chem; 1995 Sep; 270(36):21411-9. PubMed ID: 7673177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic AMP inhibition of proliferation of hepatocellular carcinoma cells is mediated by Akt.
    Liu L; Xie Y; Lou L
    Cancer Biol Ther; 2005 Nov; 4(11):1240-7. PubMed ID: 16177565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIP/PAP, a C-type lectin overexpressed in hepatocellular carcinoma, binds the RII alpha regulatory subunit of cAMP-dependent protein kinase and alters the cAMP-dependent protein kinase signalling.
    Demaugre F; Philippe Y; Sar S; Pileire B; Christa L; Lasserre C; Brechot C
    Eur J Biochem; 2004 Oct; 271(19):3812-20. PubMed ID: 15373827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sorafenib and an adenylyl cyclase activator on in vitro growth of well-differentiated thyroid cancer cells.
    Sawa A; Chiba T; Ishii J; Yamamoto H; Hara H; Kamma H
    Endocr J; 2017 Nov; 64(11):1115-1123. PubMed ID: 28855436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma.
    Wiesenauer CA; Yip-Schneider MT; Wang Y; Schmidt CM
    J Am Coll Surg; 2004 Mar; 198(3):410-21. PubMed ID: 14992744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual bradykinin B2 receptor signalling in A431 human epidermoid carcinoma cells: activation of protein kinase C is counteracted by a GS-mediated stimulation of the cyclic AMP pathway.
    Liebmann C; Graness A; Ludwig B; Adomeit A; Boehmer A; Boehmer FD; Nürnberg B; Wetzker R
    Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):109-18. PubMed ID: 8546671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple signal transduction pathways lead to extracellular ATP-stimulated mitogenesis in mammalian cells: II. A pathway involving arachidonic acid release, prostaglandin synthesis, and cyclic AMP accumulation.
    Huang NN; Wang DJ; Gonzalez F; Heppel LA
    J Cell Physiol; 1991 Mar; 146(3):483-94. PubMed ID: 1850750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compound Astragalus and Salvia miltiorrhiza extracts modulate MAPK-regulated TGF-β/Smad signaling in hepatocellular carcinoma by multi-target mechanism.
    Boye A; Wu C; Jiang Y; Wang J; Wu J; Yang X; Yang Y
    J Ethnopharmacol; 2015 Jul; 169():219-28. PubMed ID: 25934513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.
    Lowe WL; Fu R; Banko M
    Endocrinology; 1997 Jun; 138(6):2219-26. PubMed ID: 9165004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells.
    Matousovic K; Grande JP; Chini CC; Chini EN; Dousa TP
    J Clin Invest; 1995 Jul; 96(1):401-10. PubMed ID: 7615811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of erythropoietin production in a hepatocellular carcinoma cell line.
    Nakashima J; Brookins J; Fisher JW
    J Lab Clin Med; 1992 Mar; 119(3):306-14. PubMed ID: 1311742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.